Apple, Meta, and Alphabet Face the AI Test in Q1 2026 Earnings
Apple, Meta, and Alphabet report Q1 2026 earnings this month. Here’s what Wall Street expects and why AI returns are the central question.
Stock Market
March Home Sales Miss: What It Means for Housing Stocks
U.S. existing home sales fell 3.6% in March—far worse than the 0.7% consensus estimate. What the miss means for homebuilder stocks, REITs, and mortgage markets.
Pharma Giants Race to Harness AI — What It Means for Drug Stocks
From protein folding to clinical trials, AI is transforming drug discovery. Novo Nordisk’s OpenAI deal is the latest signal for pharma investors.
Big Pharma’s Tariff Reckoning: Drug Stocks Brace for 100% Duties
The Trump administration’s 100% pharmaceutical tariff threat is testing drug stock valuations, global supply chains, and corporate bond markets.
Is OpenAI Worth $852 Billion? Investors Push Back
OpenAI’s private market valuation has ballooned to $852 billion, but some of its own backers are questioning the math as the company shifts strategic focus.
Amazon’s Globalstar Bet: Inside the Satellite Race
Amazon is in advanced talks to acquire Globalstar, a move that could reshape the satellite internet race against SpaceX Starlink and trigger a new wave of space sector M&A.
ASML Q1 2026 Earnings: The AI Chip Supply Chain Signal
ASML reports Q1 2026 earnings this week. As the sole maker of EUV machines, its order book is the best indicator of where the AI chip supercycle is headed.
Microsoft Q3 FY2026 Earnings Preview: Azure and AI in the Spotlight
Microsoft reports Q3 FY2026 earnings on April 29. Here’s what analysts expect from Azure cloud growth, AI Copilot revenue, and the company’s evolving competitive position.
CoreWeave: How the GPU Cloud IPO Became Wall Street’s AI Darling
CoreWeave has surged 176% since its 2025 IPO. Here’s what the GPU cloud provider’s rise reveals about the next phase of AI infrastructure investment.
Blackstone Surges 6%: What Private Equity’s Rally Signals
Blackstone surged 6% on April 13 as private equity benefits from M&A revival, real asset demand, and surging institutional inflows to alternatives.